Abstract
Suppression of pancreatic glucagon secretion by hyperglycemia is a characteristic of normal alpha cell function. However, in diabetic subjects, plasma glucagon is normal or high despite hyperglycemia. It seemed possible that the presence of glucose or its metabolites within the alpha cell might be essential for suppression of glucagon secretion, and that in diabetes an intracellular deficiency of glucose secondary to insulin lack might be responsible for the nonsuppressibility. The present study was designed to determine the effect upon glucagon secretion of blockade of glucose metabolism and of experimental insulin deficiency.
Blockade of glucose metabolism was induced in dogs by administration of 2-deoxyglucose or mannoheptulose. A striking rise in glucagon was observed despite accompanying hyperglycemia and hyperinsulinemia, which, in the case of mannoheptulose, was induced by infusing crystalline insulin.
To determine if insulin lack also causes paradoxical hyperglucagonemia, dogs were made severely diabetic by alloxan. Fasting glucagon levels ranged from 3 to 22 times normal despite severe hyperglycemia, and were quickly restored to normal by infusing insulin. Diabetes induced in rats by anti-insulin serum was also associated with significant elevation in plasma glucagon. However, diazoxide-induced insulin lack did not increase glucagon in dogs.
It is concluded that normal suppression of glucagon secretion by hyperglycemia does not occur when glucose metabolism is blocked or when severe insulin deficiency is produced. It is suggested that normal glucose metabolism within the alpha cell may be an insulin-requiring process without which hyperglycemic suppression of glucagon release cannot occur.
Full text
PDF![1992](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/292125/3741770123ed/jcinvest00197-0220.png)
![1993](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/292125/7e6df34455bd/jcinvest00197-0221.png)
![1994](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/292125/3c677ade0828/jcinvest00197-0222.png)
![1995](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/292125/d21cfca57412/jcinvest00197-0223.png)
![1996](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/292125/b8f23db3d515/jcinvest00197-0224.png)
![1997](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/292125/45a764a1aed7/jcinvest00197-0225.png)
![1998](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/292125/e5c09b798d7a/jcinvest00197-0226.png)
![1999](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f109/292125/eb5296a877bd/jcinvest00197-0227.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Assan R., Hautecouverture G., Guillemant S., Dauchy F., Protin P., Derot M. Evolution de paramètres hormonaux (glucagon, cortisol, hormone somatotrope) et énergétiques (glucose, acides gras, glycérol libre) dans dix acido-cétoses diabétiques graves traitées. Pathol Biol (Paris) 1969 Dec;17(23):1095–1105. [PubMed] [Google Scholar]
- Buchanan K. D., Vance J. E., Dinstl K., Williams R. H. Effect of blood glucose on glucagon secretion in anesthetized dogs. Diabetes. 1969 Jan;18(1):11–18. doi: 10.2337/diab.18.1.11. [DOI] [PubMed] [Google Scholar]
- Coore H. G., Randle P. J. Inhibition of glucose phosphorylation by mannoheptulose. Biochem J. 1964 Apr;91(1):56–59. doi: 10.1042/bj0910056. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edwards J. C., Taylor K. W. Fatty acids and the release of glucagon from isolated guinea-pig islets of Langerhans incubated in vitro. Biochim Biophys Acta. 1970 Aug 14;215(2):310–315. doi: 10.1016/0304-4165(70)90029-2. [DOI] [PubMed] [Google Scholar]
- Frerichs H., Creutzfeldt C., Creutzfeldt W. [Inhibitors of insulin secretion]. Acta Diabetol Lat. 1968 Oct;5 (Suppl 1):105–123. [PubMed] [Google Scholar]
- Froesch E. R., Jakob A., Zahnd G. R., Simon E. Immunoreactive insulin, suppressible, and non suppressible insulinlike activities in rats after administration of glucose and induction of hyperglycaemia by mannoheptulose. Diabetologia. 1966 Dec;2(4):265–268. doi: 10.1007/BF01268184. [DOI] [PubMed] [Google Scholar]
- Herbert V., Lau K. S., Gottlieb C. W., Bleicher S. J. Coated charcoal immunoassay of insulin. J Clin Endocrinol Metab. 1965 Oct;25(10):1375–1384. doi: 10.1210/jcem-25-10-1375. [DOI] [PubMed] [Google Scholar]
- Müller W. A., Faloona G. R., Aguilar-Parada E., Unger R. H. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med. 1970 Jul 16;283(3):109–115. doi: 10.1056/NEJM197007162830301. [DOI] [PubMed] [Google Scholar]
- Nelson J. K., Rabinowitz D., Merimee T. J. Effect of epinephrine on insulin release in man induced by secretin. Nature. 1967 Aug 19;215(5103):883–884. doi: 10.1038/215883a0. [DOI] [PubMed] [Google Scholar]
- Ohneda A., Aguilar-Parada E., Eisentraut A. M., Unger R. H. Control of pancreatic glucagon secretion by glucose. Diabetes. 1969 Jan;18(1):1–10. doi: 10.2337/diab.18.1.1. [DOI] [PubMed] [Google Scholar]
- Ohneda A., Parada E., Eisentraut A. M., Unger R. H. Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids. J Clin Invest. 1968 Oct;47(10):2305–2322. doi: 10.1172/JCI105916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Seltzer H. S., Allen E. W. Hyperglycemia and inhibition of insulin secretion during administration of diazoxide and trichlormethiazide in man. Diabetes. 1969 Jan;18(1):19–28. doi: 10.2337/diab.18.1.19. [DOI] [PubMed] [Google Scholar]
- UNGER R. H., EISENTRAUT A. M., McCALL M. S., MADISON L. L. Measurements of endogenous glucagon in plasma and the influence of blood glucose concentration upon its secretion. J Clin Invest. 1962 Apr;41:682–689. doi: 10.1172/JCI104525. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Unger R. H., Aguilar-Parada E., Müller W. A., Eisentraut A. M. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest. 1970 Apr;49(4):837–848. doi: 10.1172/JCI106297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Unger R. H., Ketterer H., Dupré J., Eisentraut A. M. The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J Clin Invest. 1967 Apr;46(4):630–645. doi: 10.1172/JCI105565. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WICK A. N., DRURY D. R., NAKADA H. I., WOLFE J. B. Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem. 1957 Feb;224(2):963–969. [PubMed] [Google Scholar]
- WRIGHT P. H. The production of experimental diabetes by means of insulin antibodies. Am J Med. 1961 Dec;31:892–900. doi: 10.1016/0002-9343(61)90031-6. [DOI] [PubMed] [Google Scholar]
- YALOW R. S., BERSON S. A. Immunoassay of endogenous plasma insulin in man. J Clin Invest. 1960 Jul;39:1157–1175. doi: 10.1172/JCI104130. [DOI] [PMC free article] [PubMed] [Google Scholar]